Search

everythinglearnresearchcommunity

for

Search:↓

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

Many skin patients have mental health issues, so dermatologists should consider psychological care.

Trichotillomania treatment is improving with behavior therapy and new drug approaches, but challenges like stigma and underdiagnosis remain.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

Finasteride, a medication, is being re-evaluated for its effects and uses.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

The conclusion is that there's a need for a new conference to establish stricter guidelines for diagnosing Polycystic Ovary Syndrome (PCOS).

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

No current system perfectly classifies male-pattern hair loss, indicating a need for a new system for better diagnosis and treatment.

A boy with a new NR5A1 gene mutation has a sex development disorder without affecting his adrenal glands.

Targeting psychosocial factors can help reduce self-stigma in people with chronic skin diseases.

Adults with alopecia areata have a higher risk of mental health issues, especially women after COVID-19.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Dutch dermatologists prioritized skin conditions like melanoma and psoriasis for guideline development, focusing on consistent care over cost or death rates.

Women with polycystic ovarian syndrome often experience depression and anxiety.

Current drug safety systems fail to detect long-term side effects, needing improvements to protect health and trust.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Escitalopram might effectively treat delusions of parasitosis and possibly Morgellons disease, with psychological factors being important to consider.

Lower illness acceptance is linked to more body dysmorphic disorder symptoms in patients with body modifications.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

About 50% of 46, XY DSD cases lack a genetic diagnosis, but advanced sequencing methods improve detection.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.